Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Momenta (MNTA) was off $7.71 (58%) to $5.67 on 17.6 million shares after
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury